Bank Rakyat Indonesia (BBRI IJ) (Buy) - Feb-25: Improving monthly CoC

Banks EW 234 24th Mar, 2025

BBRI released its bank-only Feb-25 results. In short, we see a notable improvement in Feb-25 compared with the Jan-25 results. Feb-25 profit jumped to IDR4.6tn (+129% m-m). This, according to BBRI, is attributed to improving credit costs (CoC) in Feb-25 at ~330bp – a significant decline from the Jan-25 CoC level of ~560bp, as the management overlay associated CoC has normalized. Nevertheless, despite the decline in CoC on a monthly basis, we expect asset quality concerns to continue due to the current macroeconomic backdrop. This has, so far, brought YTD Feb-25 CoC to ~4.4% (flat y-y). We think FY25F CoC could hover at ~3.5-3.7%, which is above management’s guidance of ~3.3%.

On a YTD basis, however, headline bank-only profit was only IDR6.6tn (-18% y-y from IDR8.1tn in Jan-Feb FY24 period). And, the decline can be largely attributed to CoC as explained above. However, at the operating level, headline YTD Feb-25 net interest income and PPOP reached IDR18.3tn (-2% y-y) and IDR17.5tn (-7% y-y), respectively. This can be attributed to a lower headline NIM of 6.3% (-20bp y-y) as a result of lower asset yields (whilst funding costs have been stable at ~3.1-3.3%).

On the asset quality side, we note continually high estimated (annualized) write-off rates of 3.6% in YTD Feb-25, according to BBRI, compared with ~3.2% a year ago. This leads to risk-adjusted NIM of 3.2% YTD Feb-25 (-40bp y-y). With a still high CoC, the bank has maintained a prudent provisioning policy, resulting in an elevated stable loan-loss-reserve-ratio (LLR) of 6.0% — the highest amongst the major banks in Indonesia. We believe a high LLR is necessary to offset the risks of additional potential consensus downgrades and/or write-offs in 2025. One area of key concern to us, post the results, is that, write-off rates remain elevated.

On B/S, the bank recorded loans and deposits growth of +5.2% y-y (+0.2% YTD) and +1.5% y-y (-0.6% YTD). This translates into an LDR of 88.2% (+490bp y-y).

Post the results, despite the decline in the stock, we think BBRI continues to face challenges.

Valuation and risks

Our TP of IDR5,000 is based on a DuPont analysis assuming a risk-free rate of 6.5%, an equity risk premium of 7.8%, growth of 9.3%, beta 0.85x and a CAR-adjusted ROAE of 18.0%. We have also used 2025F book as reference. The implied multiples at our TP would be 2.3x 2025F book and 12.5x 2025F earnings.

Risks are worsening macroeconomic trends, unfavorable regulatory changes, and tighter liquidity competition which could increase funding costs, worsening credit quality which would raise credit costs, and higher opex. Changes in management may affect the bank’s write-off policies and thus, credit costs. This would ultimately affect near-term earnings for the bank.

Fig. 1: BBRI – bank-only results

 BBRI Bank-only IDR bn Feb-24Jan-25Feb-25m-my-yYTD 2025YTD 2024 y-y 
 Interest income 13,31712,99513,2182%-1%26,21327,178-4%
 Interest expenses 4,2494,0743,880-5%-9%7,9548,452-6%
 Net interest income 9,0688,9219,3395%3%18,25918,725-2%
 Monthly PPOP 10,3848,2489,19712%-11%17,44518,819-7%
 Monthly provision exp 6,4775,6273,323-41%-49%8,9498,4276%
 Monthly net profit 3,2382,0094,600129%42%6,6098,060-18%
 MoM loan growth 0.2%-0.5%0.7%     
 YoY loan growth 12.6%4.6%5.2%     
 YTD loan growth 1.1%-0.5%0.2%     
 MoM deposit growth 0.6%0.0%1.5%     
 YoY deposit growth 10.9%-1.6%-0.6%     
 YTD deposit growth 2.7%0.0%1.5%     
 LDR  83.3%88.9%88.2%     
 NIM (annualised) 6.2%6.2%6.4%  6.3%6.5% 
 LLR 6.9%6.0%6.0%  6.0%6.9% 
 CoC (annualised) 6.7%5.6%3.3%  4.4%4.4% 
 Risk-adj NIM % 1.8%2.3%4.1%  3.2%3.6% 
 CASA ratio 61%66%65%     
 CIR (annualised) 17%39%33%     
 B/S ROAE (annualised) 12.7%8.0%18.1%     
 B/S ROAA (annualised) 2.1%1.3%3.0%     
 Asset yield (annualised) 9.1%9.0%9.1%     
 COF (annualised) 3.4%3.3%3.1%     
 Leverage ratio x                6.1               6.0               6.1     
 Cash ratio % 1.3%1.5%1.3%     
 LDR %              83.4             88.9             88.2 
 Loan-to-CASA % 136.1%134.6%136.0%
 Monthly personnel exp            1,087           2,129           2,081-2%91%4,2103,52020%
Source: Company data, Verdhana research

 

Fig. 2: BBRI – earnings assets & funding

 BBRI Earnings asset IDRbn Feb-24Jan-25Feb-25m-my-yYTD 2025YTD 2024
 Total     1,755,229    1,719,621    1,760,8512%0%1%2%
 Placements w BI         117,240        117,627        127,2318%9%4%-22%
 Placements with other banks            43,423          46,072          47,6403%10%2%17%
 Marketable Securities         392,687        309,858        307,905-1%-22%-1%16%
 Repo Securities           21,489          26,964          36,42435%70%42%6%
 Reverse Repo Securities           21,881            9,583          23,252143%6%40%-34%
 Loans and receivables     1,158,510    1,209,516    1,218,3991%5%0%1%
  
 Breakdown Feb-24Jan-25Feb-25
 Total            100.0           100.0           100.0
 Placements w BI                6.7               6.8               7.2
 Placements with other banks                 2.5               2.7               2.7
 Marketable Securities              22.4             18.0             17.5
 Repo Securities                1.2               1.6               2.1
 Reverse Repo Securities                1.2               0.6               1.3
 Loans and receivables              66.0             70.3             69.2
 BBRI Funding IDRbn Feb-24Jan-25Feb-25m-my-yYTD 2025YTD 2024
 Total Assets     1,755,229    1,719,621    1,760,8512%0%1%2%
 Deposits     1,389,467    1,360,169    1,380,9172%-1%2%3%
 Current accounts         338,989        366,816        368,2160%9%-2%-2%
 Savings accounts         512,120        531,847        527,364-1%3%-3%-3%
 Time deposits         538,358        461,507        485,3375%-10%10%12%
 CASA        851,109       898,663       895,5800%5%-3%-3%
 Loans/Securities          85,273         93,351       101,8879%19%11%-7%
 Equities        306,774       301,966       307,0002%0%3%3%
  
 Breakdown % Feb-24Jan-25Feb-25  
 Total Assets            100.0           100.0           100.0  
 Deposits              79.2             79.1             78.4
 Current accounts              19.3             21.3             20.9
 Savings accounts              29.2             30.9             29.9
 Time deposits              30.7             26.8             27.6
 Loans/Securities                4.9               5.4               5.8
 Equities              17.5             17.6             17.4
Source: Company data, Verdhana research

 

Fig. 3: BBRI – 12MMA Loan vs NII growth %

Source: Company data, Verdhana research

 

Fig. 4: BBRI – 12MMA CoC vs 12MMA WO %

Source: Company data, Verdhana research

 

Fig. 5: BBRI – LLR vs 12MMA WO %

Source: Company data, Verdhana research

INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general. 

GENERAL DISCLOSURE/DISCLAIMER 
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).

This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.

The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.


This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.

ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views.  The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.


RESTRICTIONS ON DISTRIBUTION

By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations. 

Rating
Remains
Buy
Target price
Remains
IDR 5,000
Closing price
21 March 2025
IDR 3,700

Erwin Wijaya (erwin.wijaya@verdhana.id)